Pennsylvanias Premier Medical Marijuana Therapeutics

Pennsylvanias Premier Medical Marijuana Therapeutics

Pennsylvanias premier medical marijuana therapeutics, Ilera Healthcare, company and the main medical cannabis supplier for the entire state, will soon introduce a series of groundbreaking medicines whose formulation is based upon current scientific and clinical research on the effects of cannabis on chronic ailments. Ilera’s latest offering using this technique is HOPE™, which will be available in early May.  Ilera’s research and development team lead by Chief Scientific officer/EVP Dr. Oludare Odumosu.
Dr. Odumosu formulated HOPE based on research on cannabis as a possible therapy for those impacted by autism spectrum disorder (ASD).
Dr. Odumosu brings 10 years of experience in corporate pharmaceutical business development, operations and strategic alliance management to his role as Ilera Healthcare’s Chief Scientific Officer/EVP Pharmaceutical Division. His background in biochemistry and healthcare entrepreneurship gives him unique qualifications for this role. Dr. Odumosu played a critical role in Iroko Pharmaceutical’s post-clinical development of Zorvolex Tivorbex and Vivlodex through FDA approvals and successful US market commercialization. He also managed the execution of the business development gate processes for the expansion of Iroko’s Solumatrix franchise products through ex-US licensing agreement negotiations. He received a PhD in Biochemistry and a Master’s in Public Health-Epidemiology and Biostatistics from the Loma Linda University School of Medicine and School of Public Health in Loma Linda, California; and a BS in Biology from Calvin College in Grand Rapids, Michigan. Dr. Odumosu is a World Bank Institute Certified public health professional with global healthcare translational/clinical/epidemiological research and data management experience.
CBD Toothpaste Sounds Like a Good Idea but Lacks Conclusive Studies Proving It Is
Oral health care is a growing market and CBD is a booming market. Now science needs to study the benefits of combining them.